Chemical Structure (Segluromet 01)
Chemical structure of ertugliflozin and metformin hydrochloride, the active ingredients in SEGLUROMET tablets.*
Segluromet Tablet, Film Coated
Product Images NDC 0006-5369
9 FDA label images from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 0006-5369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Segluromet 02)
Chemical structure of metformin hydrochloride depicted as a molecular formula diagram illustrating its atomic composition and connectivity.*
Figure 1 (Segluromet 03)
A horizontal error bar plot showing geometric mean ratios with 90% confidence intervals for pharmacokinetic parameters AUC and Cmax of various drugs (Sitagliptin, Metformin, Glimepiride, Simvastatin, Rifampin) relative to ertugliflozin alone after a 15 mg single dose. The plot compares these parameters across different single-dose drugs with numerical values and confidence intervals displayed to the right of the bars.*
Figure 2 (Segluromet 04)
A graph showing the geometric mean ratio (90% confidence interval) of AUC and Cmax values for Sitagliptin 100 mg, Metformin 1000 mg, Glimepiride 1 mg, Simvastatin 40 mg, and Simvastatin Acid administered as Simvastatin, all relative to concomitant medication alone (%). The x-axis represents percent relative values compared to medication alone, with all ertugliflozin doses given as 15 mg single dose.*
Figure 3 (Segluromet 05)
A line graph showing the mean change from baseline in HbA1c (%) over 26 weeks and an additional 26-week extension (26-MI) for Placebo, Ertugliflozin 5 mg, and Ertugliflozin 15 mg groups. The x-axis represents the study weeks (Baseline, 6, 12, 18, 26, and 26-MI), and the y-axis represents the percent change in HbA1c. Data show a decrease in HbA1c in the ertugliflozin groups compared to placebo.*
Principal Display Panel (2.5 mg/500 mg Tablet Bottle Label)
Label for Segluromet 2.5 mg / 500 mg film-coated tablets containing ertugliflozin and metformin hydrochloride. The label shows the Merck Sharp & Dohme LLC logo, NDC 0006-5369-03, and a pink oblong tablet imprinted with "2.5/500." The package contains 60 tablets for oral use. Storage and usage instructions are partially visible.*
Principal Display Panel (2.5 mg/1,000 mg Tablet Bottle Label)
Segluromet 2.5 mg / 1000 mg film-coated tablets packaging label showing the product name with active ingredients ertugliflozin and metformin hydrochloride. The label includes dosage strength, tablet image marked "2.5/1000," quantity of 60 tablets, labeler Merck Sharp & Dohme LLC, and a barcode. Storage instructions and prescription-only status are also visible.*
Principal Display Panel (7.5 mg/500 mg Tablet Bottle Label)
Segluromet 7.5 mg / 500 mg film-coated tablets carton label. The label shows the product name, active ingredients ertugliflozin and metformin hydrochloride, strength, and quantity of 60 tablets. It includes the NDC 0006-5370-03, manufacturer Merck Sharp & Dohme LLC, and directions to dispense the accompanying Medication Guide. The red oval tablet image is embossed with '7.5/500'.*
Principal Display Panel (7.5 mg/1,000 mg Tablet Bottle Label)
Label for SEGLUROMET tablets containing ertugliflozin and metformin hydrochloride, strength 7.5 mg / 1,000 mg. The film-coated tablets are oral, prescription-only, with 60 tablets per bottle. The label includes the NDC 0006-5374-03, manufacturer Merck Sharp & Dohme LLC, and shows an image of an oval reddish-brown tablet embossed with "7.5/1000".*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
